Kaiser Family Foundation Executive Discusses Medicare Drug Pricing Legislation
Executive Vice President for Health Policy at the Kaiser Family Foundation Larry Levitt shared his thoughts on the Congressional Budget [...]
Public Health and Pharmacy Professor Reviews Recent Publication on Drug Misuse in Healthcare
University of Arizona Professor and Dean Emeritus at the University of Kansas School of Pharmacy Jack Fincham, PhD discussed a [...]
2021’s PBMI Conference Featured Lively Discussions on Specialty Drug Costs, Data Interoperability, and RWD
The Pharmacy Benefit Management Institute (PBMI) recently held its annual conference. This year, the hybrid format allowed for lively discussions [...]
Biden’s Prescription Drug Price Plan Addresses Innovation and Omits Key Topics
President Biden’s drug pricing plan was published on September 9th. It includes key policy reforms such as allowing Medicare to [...]
Intermountain Healthcare and SCL Health Announce Merger; Resulting $11 Billion Health System to Span Six States
Intermountain Healthcare and SCL Health plan to merge, leading to a health system spanning six states. The $11 billion system [...]
On-Demand Webinar on Unmet Need in Oncology Healthcare
BioPlus Specialty Pharmacy is offering an on-demand webinar featuring EVP and Oncology Practice Head at Cello Health BioConsulting Jeff Bockman, Ph.D. [...]
IQVIA Study Predicts Prescription Drug Spending Will Hit $400 Billion in 2025
IQVIA expects spending on prescription drugs to reach $400 billion in 2025, with new drug launches accounting for approximately $133 [...]
What is the Specialty Drug Commercialization Pipeline?
Specialty drugs are high cost pharmaceutical products intended for a small number of patients. The specialty drug commercialization process requires [...]
Biogen CEO Discusses Tumultuous Aduhelm Launch
Biogen CEO Michel Vounatsos recently shared his thoughts regarding the hectic Aduhelm launch at the Morgan Stanley 19th Annual Global [...]
ISPOR Article on Prescription Drug Price Variation in Last Decade
In a recent article published in Value in Health, the authors investigate pharmaceutical drug prices. They note significant variation among payers; [...]
Vesto and Oldham Global Collaborate to Offer Financing for High Cost Therapies
Crypto company Vesto and development company Oldham Global have announced a partnership to provide financing for expensive pharmaceuticals. Payers and [...]
Democrats’ Success in Drug Pricing Legislation Hinges on Select Group of Individuals
Democrats are attempting to lower drug prices through legislation. Ten individuals could determine the initiative’s outcome. “The effort’s success depends [...]
Drug Pricing App GoodRx Announces Revenue of $177 Million in Second Quarter of 2021
GoodRx has announced a 43% revenue increase in its second quarter, leading to $177 million in revenue. Its subscribers hit [...]
Congressional Budget Office’s Updated Model Predicts Impact of Pricing Legislation on Pharma Innovation
The Congressional Budget Office (CBO) released an updated model intended to predict how drug pricing bills, including Medicare negotiation, would [...]
HEOR Policy Experts Present Drug Pricing Reform Options, Discuss FDA’s Accelerated Approval Mechanism and Pricing Negotiation
Health economics and outcomes research (HEOR) experts at the USC-Brookings Schaeffer Initiative for Health Policy and the Washington University School [...]
New JMCP Article on International Reference Pricing Assesses Global Models
Drs. Leah Rand and Aaron Kesselheim recently published an article in the Journal of Managed Care and Specialty Pharmacy (JMCP) [...]
Economists and Policy Experts Discuss Six Strategies to Address High Drug Costs
Paul Ginsberg and Steven Lieberman of the USC-Brookings Schaeffer Initiative for Health Policy discuss six policies that could address the [...]
KHN Podcast Highlights Mississippi Lawyer Who Fought Against Price-Gouging by Hospitals
Price-gouging by unscrupulous healthcare systems continues to be a widespread concern. A podcast sponsored by Kaiser Health News and Public [...]
New Article Reveals Modeling Method to Evaluate Costs of Value-Based Care
A recent article, published in the American Journal of Managed Care, highlights a new method designed to evaluate the costs [...]
Diabetes Drug Priced at $1349 per Month Leads to Weight Loss, Prompting Payer Coverage Debates
Wegovy, a type 2 diabetes drug that costs $1349 per month, can lead to weight loss. This side effect is [...]
Cost-Effective Insulin Glargine Biosimilar Could Upend Reference Diabetes Drug; McKinsey Estimates Biosimilar Market Will Hit $30 Billion by 2025
The Food and Drug Administration (FDA) recently approved Semglee, an insulin glargine biosimilar product. Compared to reference drug Lantus, the [...]
Geisinger Launches AI-Powered Tool for Patients to Manage Healthcare Costs, Reports Monthly Savings of $52 per Patient
Geisinger has partnered with PayZen to offer patients an out-of-pocket payment tool. Payment plans, powered by artificial intelligence (AI), include [...]
Pharma and Patient Advocacy Groups Release Expensive Ads Ahead of Drug Price Negotiation Bill
Patient and prescription drug pricing advocacy groups, including Patients for Affordable Drugs Now, are pushing for drug legislation using expensive [...]
COVID-19 Pandemic is Hastening the Patient Financial Experience Trend
The patient financial experience (PFX) is a growing trend in healthcare, hastened by the ongoing COVID-19 pandemic. Patients are pushing [...]
Despite Legal Mandate, Hospital Pricing Data Can Be Difficult to Access
Federal legislation aimed to promote price transparency in healthcare calls for hospitals to disclose their prices. Some hospitals have not [...]